Evolution of the Average Target: Basilea Pharmaceutica AG

Evolution of the Average Target - Basilea Pharmaceutica AG

Evolution of the Target Price: Basilea Pharmaceutica AG

Evolution of the Target Price - Basilea Pharmaceutica AG

Changes in Analyst Recommendations: Basilea Pharmaceutica AG

2ce93c.heBQDXk3fZxSWpPZY6Dc96BLKBtxBLrKsFYqs21bo9Q.6YwATAFCBOoVA9rrIfefvfgzfysENvCL-Acb-zgVlpG2uBN3QGgi0wJi-A~54340e605b701898f43b0c0f5d5d92e0

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+38.55%
+38.52%
+18.89%
+8.54%
+13.54%
+21.07%
+30.77%
+68.83%
+19.8%
+59.35%
Average +31.79%
Weighted average by Cap. +28.57%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
71.50CHF
Average target price
99.62CHF
Spread / Average Target
+39.33%
High Price Target
126.10CHF
Spread / Highest target
+76.36%
Low Price Target
67.00CHF
Spread / Lowest Target
-6.29%

Analyst Consensus Detail

Analyst consensus - Basilea Pharmaceutica AG

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Basilea Pharmaceutica AG
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Basilea Pharmaceutica AG
  1. Stock Market
  2. Stocks
  3. BSLN Stock
  4. Consensus Basilea Pharmaceutica AG